Exhibit 32.2
CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. § 1350), the undersigned officer of ImmunoCellular Therapeutics, Ltd. (the “Company”) hereby certifies that, to the best of his knowledge:
1. | TheCompany’s Quarterly Report on Form 10-Q for the period ended September 30, 2013 (“Periodic Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and |
2. | The information contained in thePeriodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 7, 2013 | By: | /s/ David Fractor |
| |
| Name: | David Fractor | ||
| Title: | Principal Financial and Accounting Officer | ||
